Obesity and non-alcoholic fatty liver disease (NAFLD) are common comorbidities in patients with plaque psoriasis and psoriatic arthritis and may potentially explain the increased risk of ALT-elevations20–22. The gene discussed is GPT; the disease is psoriasis vulgaris.